NORDIC BIOSCIENCE Trademark

Trademark Overview


On Wednesday, July 19, 2023, a trademark application was filed for NORDIC BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the NORDIC BIOSCIENCE trademark a serial number of 79378675. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 10, 2024. This trademark is owned by Nordic Bioscience A/S. The NORDIC BIOSCIENCE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use

Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the de...
nordic bioscience

General Information


Serial Number79378675
Word MarkNORDIC BIOSCIENCE
Filing DateWednesday, July 19, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use
Goods and ServicesDesign and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; advice, information and assistance relating to the foregoing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNordic Bioscience A/S
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressDK

Trademark Events


Event DateEvent Description
Thursday, September 14, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 19, 2023APPLICATION FILING RECEIPT MAILED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Thursday, May 2, 2024NON-FINAL ACTION WRITTEN
Friday, May 3, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 3, 2024NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, May 3, 2024NON-FINAL ACTION WRITTEN
Saturday, May 4, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 10, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 3, 2024REFUSAL PROCESSED BY IB
Friday, May 10, 2024REFUSAL PROCESSED BY MPU